Bengaluru: India pacer Mohammed Siraj on Thursday wholeheartedly welcomed the BCCI’s decision to lift the saliva ban ahead of IPL 2025, saying it will help the bowlers find “reverse swing” even in ...

One such player, who has slightly fallen out of favour in recent months, will be pacer Mohammed Siraj. The 31-year-old has lost his place in both white-ball formats, and was not part of India's ...

Unfortunately, Afridi was on the receiving end. All this after left-arm pacer kept Seifert quiet in the first over that went run-less. Returning to bowl the third over, Afridi got belted. His over ...

Jasprit Bumrah has repeatedly rescued India from crunch situations across formats, during the T20 World Cup 2024, he proved himself the best in the business. Jasprit Bumrah is arguably the ...

Pakistan batter Khushdil Shah has been docked 50 per cent match fees for ‘inappropriate physical contact’ with NZ pacer Zakary Foulkes in the 1st T20I. Pakistan batter Khushdil Shah has been ...

Kolkata Knight Riders' tearaway pacer Umran Malik has been ruled out of the Indian Premier League's 2025 season. KKR have replaced Umran with Chetan Sakariya. Listen to Story Umran Malik's injury ...

Pakistan pacer Aamir Jamal came under scrutiny when it was found out that he, alongside several other players in the side, violated the rules and regulations set by the Pakistan Cricket Board (PCB).

Australia’s young all-rounder, Cooper Connolly, had a memorable ICC Champions Trophy semi-final debut against India. Despite an early dismissal by Mohammed Shami and dropping a catch, Connolly ...

Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to Outperform from Perform, citing a favorable valuation setup ahead of a ...

Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 EPS, expectations were $-0.13. Operator: Good day, and thank you for standing by. Welcome to the Nektar Therapeutics ...

Copyright 2025 The Associated Press. All Rights Reserved. England’s Mark Wood, right, chats with Jos Buttler during the ICC Champions Trophy cricket match between ...

Nektar Therapeutics NKTR incurred an adjusted loss per share of 15 cents in the fourth quarter of 2024, wider than the Zacks Consensus Estimate of a loss of 13 cents. In the year-ago quarter, the ...